8J12 image
Deposition Date 2023-04-12
Release Date 2023-09-27
Last Version Date 2024-10-09
Entry Detail
PDB ID:
8J12
Title:
Cryo-EM structure of the AsCas12f-sgRNA-target DNA ternary complex
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.08 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Transposase IS605 OrfB C-terminal domain-containing protein
Gene (Uniprot):cas12f1
Chain IDs:A, B
Chain Length:432
Number of Molecules:2
Biological Source:Acidibacillus sulfuroxidans
Polymer Type:polyribonucleotide
Molecule:RNA (247-MER)
Chain IDs:E (auth: C)
Chain Length:224
Number of Molecules:1
Biological Source:Acidibacillus sulfooxidans
Polymer Type:polydeoxyribonucleotide
Molecule:DNA (38-MER)
Chain IDs:C (auth: D)
Chain Length:38
Number of Molecules:1
Biological Source:Acidibacillus sulfooxidans
Polymer Type:polydeoxyribonucleotide
Molecule:DNA (38-MER)
Chain IDs:D (auth: E)
Chain Length:38
Number of Molecules:1
Biological Source:Acidibacillus sulfooxidans
Primary Citation
An AsCas12f-based compact genome-editing tool derived by deep mutational scanning and structural analysis.
Cell 186 4920 4935.e23 (2023)
PMID: 37776859 DOI: 10.1016/j.cell.2023.08.031

Abstact

SpCas9 and AsCas12a are widely utilized as genome-editing tools in human cells. However, their relatively large size poses a limitation for delivery by cargo-size-limited adeno-associated virus (AAV) vectors. The type V-F Cas12f from Acidibacillus sulfuroxidans is exceptionally compact (422 amino acids) and has been harnessed as a compact genome-editing tool. Here, we developed an approach, combining deep mutational scanning and structure-informed design, to successfully generate two AsCas12f activity-enhanced (enAsCas12f) variants. Remarkably, the enAsCas12f variants exhibited genome-editing activities in human cells comparable with those of SpCas9 and AsCas12a. The cryoelectron microscopy (cryo-EM) structures revealed that the mutations stabilize the dimer formation and reinforce interactions with nucleic acids to enhance their DNA cleavage activities. Moreover, enAsCas12f packaged with partner genes in an all-in-one AAV vector exhibited efficient knock-in/knock-out activities and transcriptional activation in mice. Taken together, enAsCas12f variants could offer a minimal genome-editing platform for in vivo gene therapy.

Legend

Protein

Chemical

Disease

Primary Citation of related structures